HTL Biotechnology took part in IMCAS 2026, one of the leading international congresses dedicated to aesthetic medicine and dermatology. This major event was an opportunity to highlight the company’s strategy, innovations, and commitment to advancing regenerative medicine through high-performance biopolymers.